Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of rhGH Administration on Visceral Adiposity and Markers of Cardiovascular Risk in Obese Adolescent Girls: Phase 2

NCT01169103 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT01169103
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01169103 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of rhGH Administration on Visceral Adiposity and Markers of Cardiovascular Risk in Obese Adolescent Girls: Phase 2
Lead sponsor
Massachusetts General Hospital
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2010
Completion date
December 31, 2014
Enrollment
22 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

obesity